Kobayashi Pharmaceutical Co., Ltd. (TYO:4967)

Kobayashi Pharmaceutical Balance Sheet

Financials in millions JPY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	47,029	62,314	50,873	71,536	96,233	95,024
Short-Term Investments	10,300	8,300	14,872	8,300	8,300	14,022
Cash & Short-Term Investments	57,329	70,614	65,745	79,836	104,533	109,046
Cash Growth	-17.72%	7.41%	-17.65%	-23.63%	-4.14%	15.59%
Receivables	34,107	52,135	49,384	52,984	47,853	55,147
Inventory	29,937	22,752	24,163	22,081	17,678	15,107
Other Current Assets	3,455	3,319	5,176	3,430	2,828	2,589
Total Current Assets	124,828	148,820	144,468	158,331	172,892	181,889
Property, Plant & Equipment	69,601	67,367	67,448	47,665	34,778	22,524
Long-Term Investments	33,991	35,128	28,421	36,083	32,123	33,177
Goodwill	7,244	7,711	9,260	9,655	7,147	7,189
Other Intangible Assets	9,352	9,703	11,414	11,959	6,160	5,469
Long-Term Deferred Tax Assets	5,530	5,264	3,087	2,647	1,750	1,489
Other Long-Term Assets	2	2	1	1	2	1
Total Assets	251,891	275,329	265,368	267,473	255,827	252,554

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	10,636	14,898	14,688	17,305	18,056	17,444
Accrued Expenses	3,025	3,052	2,840	2,705	2,553	2,486
Short-Term Debt	-	-	-	-	-	1
Current Portion of Leases	271	319	343	379	261	169
Current Income Taxes Payable	17,672	33,906	19,376	29,884	25,317	25,662
Other Current Liabilities	6,467	7,962	9,176	5,838	5,622	4,941
Total Current Liabilities	38,071	60,137	46,423	56,111	51,809	50,703
Long-Term Leases	452	359	503	608	531	460
Pension & Post-Retirement Benefits	1,006	989	1,005	939	2,034	2,019
Long-Term Deferred Tax Liabilities	-	-	1,554	2,594	1,310	1,564
Other Long-Term Liabilities	2,665	2,837	2,413	2,405	2,244	2,209
Total Liabilities	42,194	64,322	51,898	62,657	57,928	56,955

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	3,450	3,450	3,450	3,450	3,450	3,450
Additional Paid-In Capital	522	522	522	522	522	4,183
Retained Earnings	200,916	204,240	208,240	205,681	194,285	200,534
Treasury Stock	-24,768	-24,767	-24,767	-24,766	-14,482	-23,706
Comprehensive Income & Other	29,567	27,553	26,021	19,929	14,124	11,138
Total Common Equity	209,687	210,998	213,466	204,816	197,899	195,599
Minority Interest	10	9	4	-	-	-
Shareholders' Equity	209,697	211,007	213,470	204,816	197,899	195,599
Total Liabilities & Equity	251,891	275,329	265,368	267,473	255,827	252,554

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	723	678	846	987	792	630
Net Cash (Debt)	56,606	69,936	64,899	78,849	103,741	108,416
Net Cash Growth	-17.87%	7.76%	-17.69%	-23.99%	-4.31%	15.77%
Net Cash Per Share	761.47	940.78	873.03	1039.65	1344.98	1387.72
Filing Date Shares Outstanding	74.34	74.34	74.34	74.34	76.13	77.28
Total Common Shares Outstanding	74.34	74.34	74.34	74.34	76.01	77.74
Working Capital	86,757	88,683	98,045	102,220	121,083	131,186
Book Value Per Share	2820.70	2838.33	2871.53	2755.17	2603.46	2516.20
Tangible Book Value	193,091	193,584	192,792	183,202	184,592	182,941
Tangible Book Value Per Share	2597.45	2604.08	2593.42	2464.42	2428.40	2353.37

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 23, 2026

Data Sources Report a data error